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Background
•

•

•

Autoinjectors are popular spring-driven medical devices
used to self-administer insulin into the bloodstream
because of the dosage accuracy, improved patient
compliance, reduced anxiety and lower treatment costs.
The growth of delivery devices in the medical industry is
taking place at a rapid pace, and the demand for syringes,
autoinjectors, needle-free injectors, and insulin pumps is
increasing due to the increasing rate of diseases.

AutojectⓇ2

EpiPenⓇ

Advantages

Disadvantages

• Safety interlock
• Cost (~$56.99)
• Ergonomic and
• Prefilled insulin
adjustable
and assembly
• Reusable and long
required before
lifespan
each use
• Built-in needle
protection
• No assembly and
ready for
emergencies

• Cost (~$139.99)
• Short shelf-life,
and patent design
that manufacturers
profit from

Assembly

1. Connector
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Connector.FCStd

Connector.stl
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Injector
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Injector
Cover.stl

3. Plunger
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4. Spring Cone
Retainer
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Spring Cone
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Spring Cone
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5. Spring
Retainer
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Spring
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Spring
Retainer.stl

6. Syringe
Cover
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Syringe
Cover.FCStd

Syringe
Cover.stl

7. Tip

GPLv3

Tip.FCStd

Tip.stl

1. Preparation: Print components and use wire cutters to cut
approximately ¼ (20 mm) off the compression spring. Attach both
spring retainers on the sides of the smaller spring and align the railings.

Problem

6

Autoinjectors are medical devices used to treat various chronic
conditions or emergencies. However, the intellectual monopolybased patent system encourages the staggering rise in prices for
autoinjectors, reducing the accessibility to healthcare.
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Capacity: 0.5 mL,
Needle: 12.7 mm, Gauge: 29 G

Capacity: 0.3 mL,
Needle: 6 mm, Gauge: 31 G

Cost

Time (min)

1. Connector

11

$0.22

125

2. Injector Cover

39

$0.78

288

3. Plunger

5

$0.10

48

4. Spring Cone
Retainer

1

$0.02

12

5. Spring
Retainer

2

$0.04

13

6. Syringe Cover

19

$0.38

189

7. Tip

3

$0.06

39

Testing and Results
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The safety and dosing accuracy was tested by measuring
the weight of water expelled from each insulin syringe.
The percent effectiveness (E%) was calculated by dividing
the delivered weight (Wdelivered) by expected weight
!
(Wexpected): 𝐸% = !!"#$%"&"! × 100%
"'(")*"!

•

ISO standards require tolerance of ±5% for the accuracy
of syringes at 50%+ capacity. E% below 95% suggested
the full dose was not administered. The percentage of
mean drug administered (MDA%) was calculated for all
syringes, (n = number of measurements): 𝑀𝐷𝐴% =

"#%
%

•
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4. Syringe Fragment: Determine the appropriate setting to adjust the
depth of the exposed needle with the tip. Insert the prefilled syringe
through parts 4,5, and 8b and assemble it in the syringe cover.

One-way ANOVA assessed variability between syringes.
Significant differences (P < 0.05) rejected the null
hypothesis because the means were not equal.

•

5. Final Connections: Compress the large spring by pushing down the
plunger until it locks, and then immediately screw the connector on the
injector cover. Carefully attach the syringe cover, so parts 1, 2, and 6
are flush. Press the button on the injector cover to inject the syringe.

Testing indicated the entire dose was not administered
(E% > 95%) in three trials for any syringes. The 0.5 mL 8
mm 30G BD syringe had the most success (MDA% of
91.333) at 50% capacity.

•

Injections were variable between syringes, but the device
consistently administered about 80% - 90% of the volume.

1. Connector

2: Injector Cover

3: Plunger

4: Spring Cone
Retainer

5: Spring Retainer

6: Syringe Cover

7: Tip

8a: Large Spring

8b: Small Spring

Future Considerations

Compatible BD Insulin Syringes with BD Ultra-Fine Needle
Capacity: 1.0 mL,
Needle: 8 mm, Gauge: 30 G
Capacity: 0.5 mL,
Needle: 8 mm, Gauge: 30 G

Mass (g)

3. Injection Segment: Insert the large spring into the injector cover and
align the hole of the plunger with the spring. The smaller side of the
plunger should protrude from the threaded end of the injector cover.

The design will only target devices for chronic conditions such as
diabetic treatment using prefilled BD Insulin Syringes.

Capacity: 1.0 mL,
Needle: 6 mm, Gauge: 31 G
Capacity: 1.0 mL,
Needle: 12.7 mm, Gauge: 30 G

Component

2. Syringe Safety: Consult a healthcare professional to determine the
appropriate syringe and needle length for treatment. Follow the
manufacturer’s instructions specific to BD Insulin Syringes.
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Scope

STL File
Name

Instructions for Use
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Use an open hardware approach to manufacture cost-effective,
more accessible, reliable, and effective autoinjectors to become a
safe and superior alternative to commercial devices.

FreeCAD File
Name

All printed components used generic PLA ($19.95/kg), cost
$1.60 (80 g), and took 11 hours and 54 minutes to print. The
total autoinjector was $5.07, and the compression spring was
the most expensive component ($3.47).

•
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Goal

3-D Printed
Components

OpenSource
License

2. Injector
Cover

Open-source hardware and 3-D printing technology
provide an alternative to expensive commercial devices
that are more accessible and maintain performance.

Commercial
Device

Bill of Materials

Manufacturing Files

Preparation

Injection
Segment

Syringe
Fragment

Final
Connections

•

To ensure safety with medical devices, the autoinjector
must dispense all contents within the syringe.

•

To inject non-water solutions, spring force must be
sufficient to support various viscosities.

•

Future designs can scale components to support different
sizes of syringes, but extensive testing of the volumetric
measurements must be conducted first.

•

Further testing must indicate dosing accuracy with high
reproducibility to be a feasible and reliable alternative.

